Sugi Predict

Sugi Predict / Compounds / SCHEMBL10124925

SCHEMBL10124925

SCHEMBL10124925

FC(F)(F)c1ccccc1-c1ccnc2[nH]ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.58
▸ DYRK1B Q9Y463 2/20 0.58
▸ AURKB Q96GD4 2/20 0.58
▸ RET P07949 2/20 0.58
▸ IKBKB O14920 1/20 0.58
▸ CHUK O15111 1/20 0.58
▸ DAPK3 O43293 1/20 0.58
▸ JAK2 O60674 1/20 0.58
▸ PRKD3 O94806 1/20 0.58
▸ MAP4K4 O95819 1/20 0.58
▸ PAK4 O96013 1/20 0.58
▸ CSF1R P07333 1/20 0.58
▸ FGFR1 P11362 1/20 0.58
▸ PRKACA P17612 1/20 0.58
▸ FLT1 P17948 1/20 0.58
▸ LTK P29376 1/20 0.58
▸ GRK5 P34947 1/20 0.58
▸ KDR P35968 1/20 0.58
▸ MAP2K2 P36507 1/20 0.58
▸ MAPK8 P45983 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240671 0.80 AURKB (0.71) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL20783136 0.80 PRKACA (0.43) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL20765269 0.80 PIK3C3 (0.62) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL4791546 0.80 NUDT1 (0.71) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL20846121 0.79 CCNB2 (0.59) RETDAPK3MAP4K4PRKACACDK8
SCHEMBL1823256 0.79 PRKCI (0.53) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL10124933 0.78 AURKB (0.54) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL13885310 0.78 JAK2 (0.56) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL31734946 0.77 CIT (0.55) IGF1RDYRK1BAURKBRETIKBKB
SCHEMBL26953519 0.77 CIT (0.55) IGF1RDYRK1BAURKBRETIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921376-B2 Pyrrolopyridines useful as inhibitors of protein kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-12-30 — — US disclosed
US-8921376-B2 Pyrrolopyridines useful as inhibitors of protein kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-12-30 — — US disclosed
EP-1881983-B1 PYRROLOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASE VERTEX PHARMA (US) 2012-01-11 — — EP disclosed
US-20110282056-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-11-17 — — US disclosed
EP-2354140-A1 Pyrrolopyridines useful as inhibitors of protein kinase Vertex Pharmaceuticals Incorporated (US) 2011-08-10 — — EP disclosed
US-20070135466-A1 Pyrrolopyridines useful as inhibitors of protein kinase VERTEX PHARMACEUTICALS INCORPORATED 2007-06-14 — — US disclosed
US-20070135466-A1 Pyrrolopyridines useful as inhibitors of protein kinase VERTEX PHARMACEUTICALS INCORPORATED 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282056-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP3K19, MAP3K20, MAP3K1 IGF1R 562/4885DYRK1B 1040/4885AURKB 296/4885
US-20070135466-A1 Pyrrolopyridines useful as inhibitors of protein kinase JAK2, JAK1, JAK3 IGF1R 3686/4885DYRK1B 590/4885AURKB 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.